Dr. Reddy's, Takeda to bring dengue vaccine QDENGA
Dr. Reddy's Laboratories and Takeda Pharmaceutical have signed a pact to distribute QDENGA, described as India's first dengue vaccine, in the country. Subject to local regulatory processes, the vaccine is expected to be available in the first half of 2027. The agreement pairs Takeda's vaccine with Dr. Reddy's distribution reach in the Indian market.
Nabka Insight
India's first dengue vaccine and the companies behind it are examinable science/health facts.
Powered by AIKey facts
- Dr. Reddy's and Takeda Pharma signed a pact to distribute QDENGA in India.
- QDENGA is described as India's first dengue vaccine.
- Subject to regulatory clearance, it is expected to be available in the first half of 2027.
Relevant forRailways · SSC · State PSC · UPSC